China Companion Animal Health Market Size, Competitive Strategies and Segment Forecast to 2034
China Companion Animal Health Market Size- By Animal Type, By Product, By Distribution Channel, By End-use- Regional Outlook, Competitive Strategies and Segment Forecast to 2034
| Published: Jul-2025 | Report ID: HLCA25245 | Pages: 1 - 256 | Formats*: |
| Category : Healthcare | |||
China Companion Animal Health Market Introduction and Overview
According to SPER Market Research, the China Companion Animal Health Market is estimated to reach USD 3.74 billion by 2034 with a CAGR of 11.48%.
The report includes an in-depth analysis of the China Companion Animal Health Market, including market size and trends, product mix, Applications, and supplier analysis. The China Companion Animal Health market was valued at USD XX billion in 2024 and is projected to increase at a compound annual growth rate (CAGR) of XX% between 2025 and 2034. The growing pet population and rising animal diseases are driving China’s companion animal health market. Urban pets are expected to surpass 70 million, nearly twice the number of young children. This shift is linked to young people delaying families due to social and economic reasons. As pet ownership grows, so does the need for vaccines, medicines, and advanced treatments. The expanding middle class and the humanization of pets are also boosting pet healthcare spending in urban China.
By Animal Type Insights
In 2024, the dog segment led the China companion animal health market due to the growing number of pet dogs and changing attitudes toward pet ownership. With over 54 million pet dogs in the country, more owners are treating their pets like family, increasing spending on veterinary care and wellness. This trend supports continued growth in the segment.
The cat segment is projected to grow at the fastest rate, driven by rising popularity among millennials and single women. Local companies are expanding production of cat-specific products, such as canned food, while increased awareness about feline health is fueling demand for veterinary services and preventive care.
By Product Insights
The pharmaceuticals segment held the largest share in the China companion animal health market in 2024, driven by innovations in pet medications and expanding treatment options for various conditions. Regulatory advancements have further supported growth, as seen in Boehringer Ingelheim Biopharmaceuticals China's 2024 approval to supply its Shanghai facility products to EU and US markets, showcasing compliance with global standards like ICH and GxP. The diagnostics segment is expected to grow at the fastest rate. Increasing awareness about pet health, rising spending, and improved veterinary infrastructure are key factors. The NRP Group has established over 1,400 veterinary centers in 80+ cities and owns more than half of the industry's MRI/CT facilities, enhancing access to diagnostic services across China.
By Distribution Channel Insights
Hospital and clinic pharmacies dominate the China companion animal health market, as they serve as primary access points for medications, vaccines, therapies, and diagnostic kits for pets. This segment benefits from the growing network of veterinary hospitals and increased interest in veterinary education, reflecting rising demand for animal healthcare services.
The e-commerce segment is expected to witness the fastest growth in the coming years. This is driven by the digitalization of animal healthcare, ongoing research and development efforts, and the rising prevalence of chronic pet conditions.
Regional Insights
East China region leads the global companion animal health market, playing a crucial role in this dominance. Rapid urbanization, increasing disposable incomes, and growing awareness about pet health have resulted in a significant rise in pet ownership across China. This has driven demand for veterinary pharmaceuticals, vaccines, diagnostics, and preventive care products. Additionally, China’s expanding veterinary infrastructure and the presence of both domestic and international companies investing in the market have further accelerated growth. Together, these factors make China a key growth driver in the Asia Pacific companion animal health market.
Market Competitive Landscape
Key players in the Global and China Companion Animal Health Market are expanding their product lines, investing in R&D, and forming strategic collaborations to meet rising demand for quality pet care. In China, companies are focusing on localized solutions and facility expansion to gain market share. Some key players are- Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Merck & Co., Inc., Randox Laboratories, Thermo Fisher Scientific, Virbac, and Zoetis.
Recent Developments:
In April 2024, Boehringer Ingelheim International GmbH formed a partnership with Sino Biopharmaceutical, a Beijing-based drug manufacturer, to co-develop innovative healthcare products and enhance the overall health of both humans and animals. This collaboration aims to combine their strengths for better product innovation.
In November 2023, Bimeda, Inc. expanded its operations in China by opening a modern sterile injectable manufacturing facility in Shijiazhuang. The company invested USD 26.44 million in this project to strengthen its manufacturing capabilities and support growing demand in the region
Scope of the report:
| Report Metric | Details |
| Market size available for years | 2021-2034 |
| Base year considered | 2024 |
| Forecast period | 2025-2034 |
| Segments covered | By Animal Type, By Product, By Distribution Channel, By End-use |
| Regions covered | Eastern Region, Western Region, Northern Region, Southern Region |
| Companies Covered | Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Merck & Co., Inc., Randox Laboratories, Thermo Fisher Scientific, Virbac, and Zoetis. |
Key Topics Covered in the Report
- China Companion Animal Health Market Size (FY’2021-FY’2034)
- Overview of China Companion Animal Health Market
- Segmentation of China Companion Animal Health Market By Animal Type (Dogs, Cats, Equine, Others)
- Segmentation of China Companion Animal Health Market By Product (Biologics, Pharmaceuticals, Supplements, Diagnostics, Others)
- Segmentation of China Companion Animal Health Market By Distribution Channel (Retail, E-commerce, Hospital/ Clinic Pharmacies)
- Segmentation of China Companion Animal Health Market By End-use (Retail, E-commerce, Hospital/ Clinic Pharmacies)
- Statistical Snap of China Companion Animal Health Market
- Expansion Analysis of China Companion Animal Health Market
- Problems and Obstacles in China Companion Animal Health Market
- Competitive Landscape in the China Companion Animal Health Market
- Details on Current Investment in China Companion Animal Health Market
- Competitive Analysis of China Companion Animal Health Market
- Prominent Players in the China Companion Animal Health Market
- SWOT Analysis of China Companion Animal Health Market
- China Companion Animal Health Market Future Outlook and Projections (FY’2025-FY’2034)
- Recommendations from Analyst
1.Introduction
1.1.Scope of the report1.2.Market segment analysis
2.Research Methodology
2.1.Research data source2.1.1.Secondary Data2.1.2.Primary Data2.1.3.SPERs internal database2.1.4.Premium insight from KOLs2.2.Market size estimation2.2.1.Top-down and Bottom-up approach2.3.Data triangulation
4.Market Dynamics
4.1.Driver, Restraint, Opportunity and Challenges analysis
4.1.1.Drivers4.1.2.Restraints4.1.3.Opportunities4.1.4.Challenges
5.Market variable and outlook
5.1.SWOT Analysis5.1.1.Strengths5.1.2.Weaknesses5.1.3.Opportunities5.1.4.Threats5.2.PESTEL Analysis5.2.1.Political Landscape5.2.2.Economic Landscape5.2.3.Social Landscape5.2.4.Technological Landscape5.2.5.Environmental Landscape5.2.6.Legal Landscape5.3.PORTERs Five Forces5.3.1.Bargaining power of suppliers5.3.2.Bargaining power of buyers5.3.3.Threat of Substitute5.3.4.Threat of new entrant5.3.5.Competitive rivalry5.4.Heat Map Analysis
6.Competitive Landscape
6.1.China Companion Animal Health Market Manufacturing Base Distribution, Sales Area, Product Type6.2.Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in China Companion Animal Health Market
7.China Companion Animal Health Market, By Animal Type (USD Million) 2021-2034
7.1.Dogs7.2.Cats7.3.Equine7.4.Others
8.China Companion Animal Health Market, By Product (USD Million) 2021-2034
8.1.Biologics8.2.Pharmaceuticals8.3.Supplements8.4.Diagnostics8.5.Others
9.China Companion Animal Health Market, By Distribution Channel (USD Million) 2021-2034
9.1.Retail9.2.E-commerce9.3.Hospital/ Clinic Pharmacies
10. China Companion Animal Health Market, By End-use (USD Million) 2021-2034
10.1.Hospitals & Clinics10.2.Point-of-Care10.3.Others
11.China Companion Animal Health Market, (USD Million) 2021-2034
11.1.China Companion Animal Health Market Size and Market Share
12.China Companion Animal Health Market, By Region, (USD Million) 2021-2034
12.1.Eastern Region12.2.Western Region12.3.Northern Region12.4.Southern Region
13.Company Profile
13.1.Bimeda, Inc.13.1.1.Company details13.1.2.Financial outlook13.1.3.Product summary13.1.4.Recent developments13.2.Boehringer Ingelheim International GmbH13.2.1.Company details13.2.2.Financial outlook13.2.3.Product summary13.2.4.Recent developments13.3.Ceva13.3.1.Company details13.3.2.Financial outlook13.3.3.Product summary13.3.4.Recent developments13.4.Elanco13.4.1.Company details13.4.2.Financial outlook13.4.3.Product summary13.4.4.Recent developments13.5.IDEXX Laboratories13.5.1.Company details13.5.2.Financial outlook13.5.3.Product summary13.5.4.Recent developments13.6.Merck & Co., Inc.13.6.1.Company details13.6.2.Financial outlook13.6.3.Product summary13.6.4.Recent developments13.7.Randox Laboratories13.7.1.Company details13.7.2.Financial outlook13.7.3.Product summary13.7.4.Recent developments13.8.Thermo Fisher Scientific13.8.1.Company details13.8.2.Financial outlook13.8.3.Product summary13.8.4.Recent developments13.9.Virbac13.9.1.Company details13.9.2.Financial outlook13.9.3.Product summary13.9.4.Recent developments13.10.Zoetis13.10.1.Company details13.10.2.Financial outlook13.10.3.Product summary13.10.4.Recent developments13.11.Others
14.Conclusion
15.List of Abbreviations
16.Reference Links
SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.
The report is based on in-depth qualitative and quantitative analysis of the Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings. The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.
Frequently Asked Questions About This Report
China Companion Animal Health Marketis projected to reach USD 3.74 by 2034, growing at a CAGR of 11.48 % during the forecast period.
China Companion Animal Health Marketsize from 2025. The Market is expected to reach USD 3.74 by 2034, at a CAGR of 11.48% during the forecast period.
China Companion Animal Health MarketCAGR of 11.48% during the forecast period.
You can get the sample pages by clicking the link - Click Here
China Companion Animal Health Market size is USD 3.74 from 2025 to 2034.
China Companion Animal Health Market covered By Animal Type, By Product, By Distribution Channel, By End-use
The North America is anticipated to have the highest Market share in the China Companion Animal Health Market .
"
Bimeda, Inc., Boehringer Ingelheim International GmbH, Ceva, Elanco, IDEXX Laboratories, Merck & Co., Inc., Randox Laboratories, Thermo Fisher Scientific, Virbac, and Zoetis.
"
The report includes an in-depth analysis of the China Companion Animal Health Market, including market size and trends, product mix, Applications, and supplier analysis
PLACE AN ORDER
Year End Discount
Sample Report
Pre-Purchase Inquiry
NEED CUSTOMIZATION?
Request CustomizationCALL OR EMAIL US
100% Secure Payment
Related Reports
Have a glance of the Report
Our Global Clients
Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
